Skip to content
healthcare.dev

Lisinopril and Hydrochlorothiazide

NDC 71610-274, Lisinopril and Hydrochlorothiazide, tablet, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-274
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076194
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LISINOPRIL20 mg/1
  • HYDROCHLOROTHIAZIDE12.5 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
71610-274-8071610027480180 TABLET in 1 BOTTLE, PLASTIC (71610-274-80)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5eea66bd-589a-45f8-ba2c-dea66a939d59

Use it

Look up 71610-274 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-274 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-274. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.